In the same line as that announced by the Ministry of Health of the Nation, the City of Buenos Aires will contact from this Wednesday the 180 thousand older adults who were given the first dose of Sputnik V so that they can complete the scheme with any of the available drugs. It will be the decision of each one whether to accept the new turn or wait for the arrival of component 2 of the Russian vaccine.

“Scientific evidence shows that using AstraZeneca and Moderna vaccines as second doses of Sputnik-V are safe and it allows reaching a similar level of antibodies against the coronavirus, with respect to the original scheme, “said the head of Government, Horacio Rodríguez Larreta.

There are in the City around 180 thousand people who are in this situation. As detailed by the head of Government, between today and tomorrow shifts will be assigned for those who wish to complete their vaccination schedule. The first applications will be made on Friday with the Moderna vaccine.

“The evidence obtained so far shows that with the combination is possible to achieve high levels of immunity, similar to the original schemes, without increasing the presence of adverse effects. Furthermore, in the coming days there will be conclusive evidence of the use of the Sinopharm vaccine as a second dose, ”said Rodríguez Larreta.

Vaccine combination studies in CABA

The City of Buenos Aires was one of the districts that carried out its own study to evaluate the reaction of the possible combinations. In the first trial 277 people over 21 years of age participated and included the Sputnik-V, AstraZeneca and Sinopharm vaccines.

With Moderna’s arrival in the country, a new study was started with 348 more volunteers to include the American vaccine. At this stage, the possibility of using the first component of Sputnik-V as a second dose was also evaluated.

Vaccination in the City

65 percent of the porteños have already been vaccinated with at least one dose and 24.5 percent have completed the immunization schedule with the second component. This week the vaccination of boys and adolescents between 12 and 17 years old with prioritized conditions, such as diabetes, obesity and chronic respiratory diseases, among others, also began.


Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more